CD19 and neoplasm: However, a new study integrated miR‐155 into the vector of anti‐CD19 CAR‐T cells and reported an increase in the anti‐tumour functions against lymphoma in vivo and in vitro due to induction of interferon‐γ (IFN‐γ) and cytolytic activity of CAR‐T cells.80